4
JOONDAN ET AL.
COCH2CH2(CH2)10CH3), 2.22 (m, 2H, COCH2(CH2)11CH3),
3.07 (m, 2H, CH2Ph), 3.74 (s, 3H, OCH3), 4.89 (m, 1H, CH),
5.93 (d, J 8 Hz, 1H, NH), 6.77 (d, J 8 Hz, 2H, Ph), 6.99 (d,
J 8 Hz, 2H, Ph). 13C NMR (CDCl3), δ (ppm): 14.1 (CO(CH2)
12CH3), 22.7 to 31.9 (COCH2(CH2)11CH3), 36.6 (COCH2
(CH2)7CH3), 37.3 (CH2Ph), 52.4 (OCH3), 52.9 (CH), 115.6,
127.5, 130.3, 155.3 (C6H4), 172.4, 173.0 (C=O).
2.2.8 | N‐dodecanoyl L‐tyrosine dodecyl ester 8
Yield: 77%. Elem Anal Found: C, 73.425; H, 10.60;
N, 4.82; Calcd for C33H57NO4: C, 73.53; H, 10.80;
N, 4.63. ESI‐MS, m/z: 554.42 (M+ Na+). IR, νmax (cm−1):
3376, 2949, 1736. 1H NMR (DMSO),
δ
(ppm):
0.85 (m, 3H, CO(CH2)10CH3), 0.85 (m, 3H, O(CH2)11CH3),
1.23 (m, 16H, COCH2CH2(CH2)8CH3), 1.23 (m, 18H,
OCH2CH2(CH2)9CH3), 1.47 (m, 2H, COCH2CH2(CH2)
8CH3), 1.47 (m, 2H, OCH2CH2(CH2)9CH3), 2.03 (m, 2H,
COCH2(CH2)9CH3), 2.78 (m, 2H, CH2Ph), 3.96 (t, J
7 Hz, 3H, OCH2(CH2)10CH3), 4.32 (m, 1H, CH), 6.63 (d,
J 8 Hz, 2H, Ph), 6.98 (d, J 8 Hz, 2H, Ph), 8.15 (d, J
8 Hz, 1H, NH), 9.25 (s, 1H, OH). 13C NMR (CDCl3), δ
(ppm): 14.1 (CO(CH2)10CH3), 14.1 (O(CH2)11CH3), 22.7 to
31.9 (COCH2(CH2)9CH3), 22.7 to 31.9 (OCH2(CH2)10CH3),
35.5 (CH2Ph), 36.5 (COCH2(CH2)9CH3), 54.5 (CH), 64.8
(OCH2(CH2)10CH3), 115.5, 127.8, 130.4, 156.5 (C6H4),
172.4, 173.7 (C=O).
2.2.5
| N‐palmitoyl L‐tyrosine methyl ester 5
Yield: 71%. Elem Anal Found: C, 72.16; H, 10.87; N,
4.20; Calcd for C26H43NO4: C, 72.02; H, 10.00; N, 3.93.
IR, νmax (cm−1): 3376, 2949, 1736. 1H NMR (CDCl3),
δ (ppm): 0.89 (t, J 7 Hz, 3H, CO(CH2)14CH3), 1.26
(m, 24H, COCH2CH2(CH2)12CH3), 1.57 (m, 2H,
COCH2CH2(CH2)12CH3), 2.19 (m, 2H, COCH2(CH2)
13CH3), 3.04 (m, 2H, CH2Ph), 3.75 (s, 3H, OCH3), 4.87 (m,
1H, CH), 5.90 (d, J 8 Hz, 1H, NH), 6.73 (d, J 8 Hz, 2H, Ph),
6.97 (d, J 8 Hz, 2H, Ph). 13C NMR (CDCl3), δ (ppm): 14.1
(CO(CH2)12CH3), 22.7 to 31.9 (COCH2(CH2)11CH3), 36.6
(COCH2(CH2)7CH3), 37.2 (CH2Ph), 52.4 (OCH3), 53.1
(CH), 115.5, 127.6, 130.4, 155.0 (C6H4), 172.4, 172.9 (C=O).
2.3 | Critical micelle concentration determination
2.3.1
| Critical micelle concentration determination of 2‐8
Pyrene was used as a fluorescence probe to determine the
critical micelle concentration (CMC) of the N‐acyl tyrosine
surfactants (compounds 2‐8) in aqueous solution at 25°C.
Stock solution of pyrene in methanol (10 μL, 0.1mM) was
transferred into vials. After evaporating the methanol, surfac-
tant solutions (3 mL) of varying concentrations were added to
the vials to give a final concentration of 1.6μM of pyrene in
each vial. Fluorescence spectra of pyrene were recorded over
the spectral range 350 to 450 nm. The excitation wavelength
was kept at 334 nm, and the emission was recorded at 373 (I1)
and 384 (I3) nm. The ratio of the intensities of the first and
third vibronic peaks in the fluorescence spectrum of pyrene
(I1/I3) was recorded as a function of the N‐acyl surfactant
concentrations to determine the CMCs.
2.2.6
| N‐stearoyl L‐tyrosine methyl ester 6
Yield: 65%. Elem Anal Found: C, 71.95; H, 11.91; N,
3.20; Calcd for C28H47NO4: C, 72.34; H, 11.26; N, 3.03.
IR, νmax (cm−1): 3376, 2949, 1736 1H NMR
(CDCl3), δ (ppm): 0.89 (m, 3H, CO(CH2)16CH3), 1.26
(m, 28H, COCH2CH2(CH2)14CH3), 1.61 (m, 2H,
COCH2CH2(CH2)14CH3), 2.19 (m, 2H, COCH2(CH2)
15CH3), 3.05 (m, 2H, CH2Ph), 3.74 (s, 3H, OCH3), 4.87 (m,
1H, CH), 5.97 (d, J 8 Hz,1H, NH), 6.74 (d, J 8 Hz, 2H, Ph),
6.95 (d, J 8 Hz, 2H, Ph). 13C NMR (CDCl3), δ (ppm): 14.1
(CO(CH2)16CH3), 22.7 to 31.9 (COCH2(CH2)15CH3), 36.6
(COCH2(CH2)15CH3), 37.2 (CH2Ph), 52.4 (OCH3), 53.1
(CH), 115.5, 127.5, 130.4, 155.1 (C6H4), 172.4, 173.0
(C=O).
2.3.2
| Critical micelle concentration determination of
SDS/CTAB–8 mixed system.
Mixed SDS‐8 systems with varying mole fractions of 8 (0,
0.2, 0.4, 0.6, 0.8, 1) were prepared by mixing precalculated
volumes of the stock solutions of SDS and 8 in water, and
the solutions were stirred for 1 hour. Mixed CTAB‐8 systems
were also prepared in a similar way, and the mole fraction of
8 in the mixed solution was expressed as
2.2.7
| N‐oleoyl L‐tyrosine methyl ester 7
Yield: 78%. IR, νmax (cm−1): 3376, 2949, 1736. H NMR
(CDCl3), δ (ppm): 0.86 (m, 3H, CO(CH2)7–CH=CH–(CH2)
7CH3), 1.25 (m, 20H, COCH2CH2(CH2)4CH2–CH=CH–CH2
(CH2)6CH3), 1.54 (m, 2H, COCH2CH2(CH2)4CH2–
CH=CH–CH2(CH2)6CH3), 2.16 (m, 2H, COCH2(CH2)6–
CH=CH–(CH2)7CH3), 3.00 (m, 2H, CH2Ph), 3.71 (s, 3H,
OCH3), 4.86 (m, 1H, CH), 5.34 (m, 2H, CO(CH2)7–
CH=CH–(CH2)7CH3), 5.96 (d, J 8 Hz, 1H, NH), 6.73 (d, J
8 Hz, 2H, Ph), 6.93 (d, J 8 Hz, 2H, Ph). 13C NMR (CDCl3), δ
(ppm): 14.1 (CO(CH2)7–CH=CH–(CH2)7CH3), 22.7 to 31.9
(COCH2(CH2)6–CH=CH–(CH2)7CH3), 36.6 (COCH2(CH2)
6–CH=CH–(CH2)7CH3), 37.3 (CH2Ph), 52.4 (OCH3), 53.2
(CH), 115.6, 127.0, 130.3, 155.6 (C6H4), 129.8, 130.0 (CO
(CH2)7–CH=CH–(CH2)7CH3), 172.4, 173.3 (C=O).
1
½8ꢀ
α8 ¼
½8ꢀ þ ½SDS=CTABꢀ
where [8], [SDS], and [CTAB] are the concentrations of the
Gemini surfactant 8, SDS, and CTAB in the mixed solutions,
respectively.
The CMC of the different mixed systems was determined
via conductivity measurements by adding successive